BSE filing, NSE: SARVOTTAM. Summary written from the filing by ALFA Finder's alert engine.
Sarvottam Finvest Ltd: key numbers
- Share price
- ₹15.00
- Market cap
- ₹11.25 Cr
- Revenue (annual)
- ₹1.37 Cr
- Net profit (annual)
- ₹-0.19 Cr
- P/E (TTM)
- -53.6×Sector 19.7×
- Promoter holding
- 24.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sarvottam Finvest Ltd
All →Sarvottam Finvest Annual General Meeting
Sarvottam Finvest Ltd held its 47th Annual General Meeting on September 29, 2026. Shareholders adopted financial statements and approved the re-appointment of the Managing Director.
Sarvottam Finvest Other Announcement
Sarvottam Finvest has dispatched letters to shareholders with unregistered email addresses, providing web-links to access the Notice of the 47th AGM and the Annual Report.
Sarvottam Finvest Management Change
Sarvottam Finvest Limited has re-appointed Mr. Dilip Kumar Gupta as Managing Director for a five-year term starting October 1, 2026, pending shareholder approval.
- Execution
- 5 years
Sarvottam Finvest Annual General Meeting
Sarvottam Finvest Limited scheduled its 47th Annual General Meeting for September 29, 2026. The board also re-appointed Mr. Dilip Kumar Gupta as Managing Director for five years.
Sarvottam Finvest Management Change
Sarvottam Finvest Limited has appointed Mr. Ravi Prakash Choudhary as the Chief Financial Officer (CFO), effective August 13, 2026.
Sarvottam Finvest Board Meeting Outcome
Sarvottam Finvest Limited appointed Mr. Ravi Prakash Choudhary as the Chief Financial Officer and Key Managerial Personnel, effective August 13, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.